• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Comparison between 3-Nitrooxyphenyl acetylsalicylate (NO-ASA) and O2-(acetylsalicyloxymethyl)-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate (NONO-ASA) as safe anti-inflammatory, analgesic, antipyretic, antioxidant prodrugs.3-硝基苯乙酰水杨酸(NO-ASA)与 O2-(乙酰水杨酰氧基甲基)-1-(吡咯烷-1-基)二氮烯-1,2-二醇(NONO-ASA)作为安全的抗炎、镇痛、解热、抗氧化前药的比较。
J Pharmacol Exp Ther. 2010 Nov;335(2):443-50. doi: 10.1124/jpet.110.171017. Epub 2010 Aug 2.
2
NOSH-sulindac (AVT-18A) is a novel nitric oxide- and hydrogen sulfide-releasing hybrid that is gastrointestinal safe and has potent anti-inflammatory, analgesic, antipyretic, anti-platelet, and anti-cancer properties.NOSH-舒林酸(AVT-18A)是一种新型的释放一氧化氮和硫化氢的杂合物,对胃肠道安全,具有强大的抗炎、镇痛、解热、抗血小板和抗癌特性。
Redox Biol. 2015 Dec;6:287-296. doi: 10.1016/j.redox.2015.08.012. Epub 2015 Aug 14.
3
Novel nonsteroidal antiinflammatory drugs possessing a nitric oxide donor diazen-1-ium-1,2-diolate moiety: design, synthesis, biological evaluation, and nitric oxide release studies.新型含一氧化氮供体二氮烯-1,2-二醇盐部分的非甾体抗炎药:设计、合成、生物学评价及一氧化氮释放研究。
J Med Chem. 2005 Jun 16;48(12):4061-7. doi: 10.1021/jm050211k.
4
NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid has enhanced chemo-preventive properties compared to aspirin, is gastrointestinal safe with all the classic therapeutic indications.NOSH-阿司匹林(NBS-1120)是一种新型的释放一氧化氮和硫化氢的复合物,与阿司匹林相比具有更强的化学预防特性,在所有经典治疗适应症方面胃肠道安全性良好。
Biochem Pharmacol. 2015 Dec 15;98(4):564-72. doi: 10.1016/j.bcp.2015.09.014. Epub 2015 Sep 21.
5
Nitroxide derivatives of non-steroidal anti-inflammatory drugs exert anti-inflammatory and superoxide dismutase scavenging properties in A459 cells.非甾体类抗炎药物的氮氧化物衍生物在 A459 细胞中发挥抗炎和超氧化物歧化酶清除作用。
Br J Pharmacol. 2012 Feb;165(4b):1058-67. doi: 10.1111/j.1476-5381.2011.01527.x.
6
Dinitroglyceryl and diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of aspirin, indomethacin and ibuprofen: synthesis, biological evaluation and nitric oxide release studies.阿司匹林、吲哚美辛和布洛芬的二硝基甘油酯和重氮-1-鎓-1,2-二醇化一氧化氮供体酯前药:合成、生物学评价及一氧化氮释放研究
Bioorg Med Chem Lett. 2009 Jun 1;19(11):3014-8. doi: 10.1016/j.bmcl.2009.04.059. Epub 2009 Apr 20.
7
Cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal anti-inflammatory drugs and gastric mucosal responses.环氧化酶-2选择性及释放一氧化氮的非甾体抗炎药与胃黏膜反应
J Physiol Pharmacol. 1998 Dec;49(4):501-13.
8
Diazen-1-ium-1,2-diolated nitric oxide donor ester prodrugs of 5-(4-hydroxymethylphenyl)-1-(4-aminosulfonylphenyl)-3-trifluoromethyl-1H-pyrazole and its methanesulfonyl analog: synthesis, biological evaluation and nitric oxide release studies.5-(4-羟甲基苯基)-1-(4-氨磺酰基苯基)-3-三氟甲基-1H-吡唑及其甲磺酰基类似物的重氮-1-鎓-1,2-二醇盐一氧化氮供体酯前药:合成、生物学评价及一氧化氮释放研究
Bioorg Med Chem. 2008 Nov 15;16(22):9694-8. doi: 10.1016/j.bmc.2008.10.001. Epub 2008 Oct 5.
9
Second-generation aspirin and indomethacin prodrugs possessing an O(2)-(acetoxymethyl)-1-(2-carboxypyrrolidin-1-yl)diazenium-1,2-diolate nitric oxide donor moiety: design, synthesis, biological evaluation, and nitric oxide release studies.具有O(2)-(乙酰氧基甲基)-1-(2-羧基吡咯烷-1-基)重氮鎓-1,2-二醇盐一氧化氮供体部分的第二代阿司匹林和吲哚美辛前药:设计、合成、生物学评价及一氧化氮释放研究
J Med Chem. 2008 Mar 27;51(6):1954-61. doi: 10.1021/jm701450q. Epub 2008 Feb 29.
10
O2-acetoxymethyl-protected diazeniumdiolate-based NSAIDs (NONO-NSAIDs): synthesis, nitric oxide release, and biological evaluation studies.基于O2-乙酰氧基甲基保护的重氮二醇酸盐的非甾体抗炎药(NONO-NSAIDs):合成、一氧化氮释放及生物学评价研究。
Bioorg Med Chem. 2007 Jul 15;15(14):4767-74. doi: 10.1016/j.bmc.2007.05.009. Epub 2007 May 6.

引用本文的文献

1
Fifty Years of Diazeniumdiolate Research: A Tribute to Dr. Larry K. Keefer.五十年来的 Diazeniumdiolate 研究:向拉里·K·基弗博士致敬。
Crit Rev Oncog. 2023;28(1):47-55. doi: 10.1615/CritRevOncog.2023048491.
2
Acetylsalicylic Acid-Primus Inter Pares in Pharmacology.乙酰水杨酸——药理学中的首屈一指。
Molecules. 2022 Dec 1;27(23):8412. doi: 10.3390/molecules27238412.
3
Discovery and Development of a Novel mPGES-1/5-LOX Dual Inhibitor LFA-9 for Prevention and Treatment of Chronic Inflammatory Diseases.新型mPGES-1/5-LOX双重抑制剂LFA-9用于预防和治疗慢性炎症性疾病的发现与开发
J Inflamm Res. 2020 Dec 31;13:1261-1278. doi: 10.2147/JIR.S286110. eCollection 2020.
4
Pharmacokinetics and pharmacodynamics of nitric oxide mimetic agents.一氧化氮模拟药物的药代动力学和药效学。
Nitric Oxide. 2019 Mar 1;84:69-78. doi: 10.1016/j.niox.2019.01.001. Epub 2019 Jan 11.
5
The dichotomous role of HS in cancer cell biology? Déjà vu all over again.HS 在癌细胞生物学中的双重角色?似曾相识。
Biochem Pharmacol. 2018 Mar;149:205-223. doi: 10.1016/j.bcp.2018.01.042. Epub 2018 Feb 14.
6
Prodrugs of NSAIDs: A Review.非甾体抗炎药的前体药物:综述
Open Med Chem J. 2017 Nov 30;11:146-195. doi: 10.2174/1874104501711010146. eCollection 2017.
7
Analysis of Post-Traumatic Brain Injury Gene Expression Signature Reveals Tubulins, Nfe2l2, Nfkb, Cd44, and S100a4 as Treatment Targets.创伤性脑损伤后基因表达特征分析显示微管蛋白、Nfe2l2、Nfkb、Cd44 和 S100a4 可作为治疗靶点。
Sci Rep. 2016 Aug 17;6:31570. doi: 10.1038/srep31570.
8
Gastrointestinal safety, chemotherapeutic potential, and classic pharmacological profile of NOSH-naproxen (AVT-219) a dual NO- and H2S-releasing hybrid.NOSH-萘普生(AVT-219)为一种新型双重一氧化氮(NO)和硫化氢(H2S)供体化合物,兼具胃肠道安全性、化疗潜力和经典药理学特性。
Pharmacol Res Perspect. 2016 Mar 4;4(2):e00224. doi: 10.1002/prp2.224. eCollection 2016 Apr.
9
NOSH-aspirin (NBS-1120), a novel nitric oxide- and hydrogen sulfide-releasing hybrid has enhanced chemo-preventive properties compared to aspirin, is gastrointestinal safe with all the classic therapeutic indications.NOSH-阿司匹林(NBS-1120)是一种新型的释放一氧化氮和硫化氢的复合物,与阿司匹林相比具有更强的化学预防特性,在所有经典治疗适应症方面胃肠道安全性良好。
Biochem Pharmacol. 2015 Dec 15;98(4):564-72. doi: 10.1016/j.bcp.2015.09.014. Epub 2015 Sep 21.
10
Synthesis and biological activity of NOSH-naproxen (AVT-219) and NOSH-sulindac (AVT-18A) as potent anti-inflammatory agents with chemotherapeutic potential.具有化疗潜力的强效抗炎药NOSH-萘普生(AVT-219)和NOSH-舒林酸(AVT-18A)的合成及生物活性
Medchemcomm. 2013;4(11). doi: 10.1039/C3MD00185G.

本文引用的文献

1
Role of nitric oxide in physiology and pathology of the gastrointestinal tract.一氧化氮在胃肠道生理和病理中的作用。
Mini Rev Med Chem. 2008 Dec;8(14):1549-60. doi: 10.2174/138955708786786462.
2
Indomethacin decreases arachidonic acid uptake in HCA-7 human colon cancer cells.吲哚美辛可降低HCA - 7人结肠癌细胞中花生四烯酸的摄取。
J Pharmacol Sci. 2008 Nov;108(3):389-92. doi: 10.1254/jphs.08167sc. Epub 2008 Nov 6.
3
NSAID-induced gastrointestinal damage and the design of GI-sparing NSAIDs.非甾体抗炎药引起的胃肠道损伤及胃肠道选择性非甾体抗炎药的设计
Curr Opin Investig Drugs. 2008 Nov;9(11):1151-6.
4
Prostaglandins, NSAIDs, and gastric mucosal protection: why doesn't the stomach digest itself?前列腺素、非甾体抗炎药与胃黏膜保护:胃为何不会自我消化?
Physiol Rev. 2008 Oct;88(4):1547-65. doi: 10.1152/physrev.00004.2008.
5
Acetylsalicylic acid and salicylic acid decrease tumor cell viability and glucose metabolism modulating 6-phosphofructo-1-kinase structure and activity.乙酰水杨酸和水杨酸通过调节6-磷酸果糖-1-激酶的结构和活性来降低肿瘤细胞活力和葡萄糖代谢。
Biochem Pharmacol. 2009 Jan 1;77(1):46-53. doi: 10.1016/j.bcp.2008.09.020. Epub 2008 Sep 21.
6
4 years after withdrawal of rofecoxib: where do we stand today?罗非昔布撤市4年后:我们如今处于什么状况?
Rheumatol Int. 2008 Oct;28(12):1187-95. doi: 10.1007/s00296-008-0650-4. Epub 2008 Jul 29.
7
Protective effects of NSAIDs on the development of Alzheimer disease.非甾体抗炎药对阿尔茨海默病发展的保护作用。
Neurology. 2008 May 6;70(19):1672-7. doi: 10.1212/01.wnl.0000311269.57716.63.
8
Second-generation aspirin and indomethacin prodrugs possessing an O(2)-(acetoxymethyl)-1-(2-carboxypyrrolidin-1-yl)diazenium-1,2-diolate nitric oxide donor moiety: design, synthesis, biological evaluation, and nitric oxide release studies.具有O(2)-(乙酰氧基甲基)-1-(2-羧基吡咯烷-1-基)重氮鎓-1,2-二醇盐一氧化氮供体部分的第二代阿司匹林和吲哚美辛前药:设计、合成、生物学评价及一氧化氮释放研究
J Med Chem. 2008 Mar 27;51(6):1954-61. doi: 10.1021/jm701450q. Epub 2008 Feb 29.
9
Protective effects of aspirin against oxidized LDL-induced inflammatory protein expression in human endothelial cells.阿司匹林对氧化型低密度脂蛋白诱导人内皮细胞炎症蛋白表达的保护作用。
J Cardiovasc Pharmacol. 2008 Jan;51(1):32-7. doi: 10.1097/FJC.0b013e318159ebaf.
10
Aspirin: recent developments.阿司匹林:近期进展
Cell Mol Life Sci. 2008 Feb;65(3):354-8. doi: 10.1007/s00018-007-7449-4.

3-硝基苯乙酰水杨酸(NO-ASA)与 O2-(乙酰水杨酰氧基甲基)-1-(吡咯烷-1-基)二氮烯-1,2-二醇(NONO-ASA)作为安全的抗炎、镇痛、解热、抗氧化前药的比较。

Comparison between 3-Nitrooxyphenyl acetylsalicylate (NO-ASA) and O2-(acetylsalicyloxymethyl)-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate (NONO-ASA) as safe anti-inflammatory, analgesic, antipyretic, antioxidant prodrugs.

机构信息

Department of Physiology and Pharmacology, City University of New York Medical School, 138th St. and Convent Ave., New York, NY 10031, USA.

出版信息

J Pharmacol Exp Ther. 2010 Nov;335(2):443-50. doi: 10.1124/jpet.110.171017. Epub 2010 Aug 2.

DOI:10.1124/jpet.110.171017
PMID:20679133
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2967407/
Abstract

Chronic inflammation is an underlying etiological factor in carcinogenesis; nonsteroidal anti-inflammatory drugs (NSAIDs) and their chemically modified NO-releasing prodrugs (NO-NSAIDs) are promising chemopreventive agents. The aim of this study was to conduct a head-to-head comparison between two NO-ASAs possessing different NO donor groups, an organic nitrate [3-nitrooxyphenyl acetylsalicylate (NO-ASA; NCX-4016)] and an N-diazeniumdiolate [NONO-ASA, O(2)- (acetylsalicyloxymethyl)-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate (NONO-ASA; CVM-01)], as antiulcerogenic, analgesic, anti-inflammatory, and antipyretic agents. All drugs were administered orally at equimolar doses. For antiulcerogenic study, 6 h after administration, the number and size of hemorrhagic lesions in stomachs from euthanized animals were counted. Tissue samples were frozen for prostaglandin E(2) (PGE(2)), superoxide dismutase (SOD), and malondialdehyde determination. For anti-inflammatory study, 1 h after drug administration, the volume of carrageenan-induced rat paw edemas was measured for 6 h. For antipyretic study, 1 h after dosing, fever was induced by intraperitoneal LPS, and body core temperatures measured for 5 h. For analgesic study, time-dependent analgesic effect of prodrugs was evaluated by carrageenan-induced hyperalgesia. Drugs were administered 30 min after carrageenan. NO-ASA and NONO-ASA were equipotent as analgesic and anti-inflammatory agents but were better than aspirin. Despite a drastic reduction of PGE(2) in stomach tissue, both prodrugs were devoid of gastric side effects. Lipid peroxidation induced by aspirin was higher than that observed by prodrugs. SOD activity induced by both prodrugs was similar, but approximately 2-fold higher than that induced by aspirin. CVM-01 is as effective as NCX-4016 in anti-inflammatory, analgesic, and antipyretic assays in vivo, and it showed an equivalent safety profile in the stomach. These results underscore the use of N-diazeniumdiolate moieties in drug design.

摘要

慢性炎症是致癌作用的一个潜在病因;非甾体抗炎药(NSAIDs)及其化学修饰的一氧化氮供体前药(NO-NSAIDs)是很有前途的化学预防剂。本研究的目的是对两种具有不同一氧化氮供体基团的 NO-ASA 进行头对头比较,一种是有机硝酸盐[3-硝基氧苯乙酰水杨酸(NO-ASA;NCX-4016)],另一种是 N-二氮烯二酸盐[N-(乙酰水杨酰氧基甲基)-1-(吡咯烷-1-基)二氮烯-1-1,2-二醇盐(NONO-ASA;CVM-01)],作为抗溃疡、镇痛、抗炎和退热剂。所有药物均以等摩尔剂量口服给药。在抗溃疡研究中,给药 6 小时后,对安乐处死动物的胃中出血性病变的数量和大小进行计数。组织样品被冷冻,用于测定前列腺素 E2(PGE2)、超氧化物歧化酶(SOD)和丙二醛。在抗炎研究中,给药后 1 小时,测量角叉菜胶诱导的大鼠足肿胀体积 6 小时。在退热研究中,给药后 1 小时,通过腹腔内 LPS 诱导发热,5 小时测量核心体温。在镇痛研究中,通过角叉菜胶诱导的痛觉过敏评估前药的时间依赖性镇痛作用。给药后 30 分钟给予药物。NO-ASA 和 NONO-ASA 作为镇痛和抗炎剂与阿司匹林具有同等效力,但优于阿司匹林。尽管胃组织中 PGE2 明显减少,但两种前药均无胃部副作用。阿司匹林引起的脂质过氧化高于观察到的前药。两种前药诱导的 SOD 活性相似,但比阿司匹林高约 2 倍。CVM-01 在体内抗炎、镇痛和退热试验中与 NCX-4016 同样有效,在胃中表现出相同的安全性。这些结果强调了在药物设计中使用 N-二氮烯二酸盐部分。